Champions Oncology, Inc.
Biotechnology ResearchNew Jersey, United States51-200 Employees
Champions Oncology, Inc. is a mid-sized biotechnology research firm based in Hackensack, New Jersey, that provides end-to-end solutions to support oncology drug development. Its offerings cover the spectrum from in vitro screening to in vivo testing, enabling clients to inform clinical development decisions. Central to its work is the Champions TumorGraft platform, a curated collection of patient-derived xenograft models that preserve human tumor biology and aim to predict clinical outcomes. The company also conducts tumor sensitivity and resistance testing across single and combination therapies, alongside biomarker discovery and exploration of novel drug combinations. Its customers include pharmaceutical and biotechnology developers, clinical oncologists, and oncology research institutions, served through a Clinical Collaboration Network and the Personalized Oncology Solutions program that help analyze patient data and coordinate testing. In the biotech landscape, Champions Oncology functions as a translational research provider that integrates tumor models with molecular and clinical data to inform treatment strategies. In May 2026, the company announced scalable Chem-Seq and Functional-Seq platforms, signaling an expansion of its platform capabilities.
1-888-653-2347 
support@leadiq.com 
